ArticleDiabetes, obesity & metabolism2026
Sex-Specific Associations of Inflammatory Biomarkers With All-Cause and Cardiovascular Mortality Across Glycaemic Status: A Prospective UK Biobank Study.
Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsTo explore sex-specific heterogeneity in the prognostic discrimination of inflammatory markers for mortality across different glycaemic states.
methodsThis prospective cohort study included 450 438 participants from the UK Biobank (median follow-up: 15.3 years), stratified by sex and glycaemic status. Cox models were applied to evaluate associations between eight inflammatory markers-CRP, WBC, neutrophil-to-lymphocyte ratio (NLR), CRP-to-lymphocyte ratio (CLR), inflammatory burden index (IBI), systemic immune-inflammation index (SII), pan-immune-inflammation value (PIV), and systemic inflammation response index (SIRI)-and all-cause and cardiovascular mortality, with markers analysed in parallel using independent models. Dose-response associations and discriminative performance were assessed using restricted cubic splines (RCS) and time-dependent receiver operating characteristic (ROC) analyses, respectively. Spearman correlation analyses were conducted to contextualize relationships between inflammatory markers and cardiometabolic phenotypes.
resultsDeteriorating glycaemic status was associated with progressively higher all-cause and cardiovascular mortality in both sexes, together with sex-specific differences in inflammatory marker trajectories. As glycaemia worsened, the discriminative performance of inflammatory markers for mortality tended to attenuate in women but remained generally more stable in men. Time-dependent ROC analyses suggested stage- and sex-specific heterogeneity. In diabetes, NLR showed stronger early discrimination in women, whereas SIRI showed more stable discrimination in men and at later follow-up in women.
conclusionInflammatory biomarkers show sex- and glycaemia-specific patterns in mortality discrimination, with NLR and SIRI showing comparatively stable discrimination, particularly in diabetes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.